Published in Int J Cancer on September 04, 1995
p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci U S A (1997) 1.24
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J Control Release (2013) 0.89
Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. Br J Cancer (1998) 0.89
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status. Br J Cancer (1998) 0.88
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials (2014) 0.83
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med (1990) 3.69
Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet (1990) 3.46
Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys (1995) 2.35
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst (1996) 2.19
The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect. Br J Cancer (1974) 2.12
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 2.11
Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys (1990) 2.07
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys (1982) 2.05
Influence of preirradiation of lung on development of artificial pulmonary metastases of fibrosarcoma in mice. Cancer Res (1973) 1.96
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
A physical concept of soil-water equilibria for nonionic organic compounds. Science (1979) 1.88
Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys (1995) 1.70
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys (1997) 1.70
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Antitumor activity of Corynebacterium parvum. Adv Cancer Res (1978) 1.62
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys (1995) 1.60
Is it time for a new formalism to categorize normal tissue radiation injury? Int J Radiat Oncol Biol Phys (2001) 1.58
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol (1995) 1.58
What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.55
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.53
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res (1999) 1.48
Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst (1979) 1.48
Alteration in myelin-associated proteins following spinal cord irradiation in guinea pigs. Int J Radiat Oncol Biol Phys (1992) 1.47
Quality assurance in a Radiation Oncology Unit: the Chart Round experience. Australas Radiol (2001) 1.45
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys (1995) 1.44
Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. Cancer J Sci Am (1999) 1.44
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 1.40
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res (1974) 1.39
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys (1995) 1.37
Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner. Med J Aust (1999) 1.36
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer (1994) 1.35
Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys (1997) 1.33
Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer (1995) 1.31
Gradual regeneration of mouse testicular stem cells after exposure to ionizing radiation. Radiat Res (1978) 1.28
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys (1990) 1.27
Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res (1997) 1.27
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys (1983) 1.25
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol (1995) 1.24
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Clin Cancer Res (1999) 1.24
A new isoeffect curve for change in dose per fraction. Radiother Oncol (1983) 1.23
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res (2000) 1.22
Tissue tolerance to reirradiation. Semin Radiat Oncol (2000) 1.17
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol (1997) 1.17
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) Int J Radiat Oncol Biol Phys (2000) 1.16
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res (2000) 1.14
Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon. Br J Cancer (1975) 1.13
Patterns of recurrence in malignant mixed müllerian tumor of the uterus. Cancer (1986) 1.10
Conditioning of tissues for metastasis formation by radiation and cytotoxic drugs. Symp Fundam Cancer Res (1983) 1.10
Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys (1990) 1.10
Inhibition of artificial lung metastases in mice by pre-irradiation of abdomen. Br J Cancer (1980) 1.09
A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer (1975) 1.09
Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol (1999) 1.08
The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity. Cancer Res (1977) 1.07
The efficacy of postoperative radiotherapy for advanced head and neck cancer: quality of the evidence. Int J Radiat Oncol Biol Phys (1998) 1.07
A usability evaluation for telemedicine medical equipment. Telemed J (1999) 1.06
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys (2001) 1.05
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. Int J Oncol (2001) 1.05
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol (1993) 1.05
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Clin Cancer Res (2000) 1.05
Effect of dose-rate on total body irradiation: lethality and pathologic findings. Radiother Oncol (1985) 1.04
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer (1991) 1.04
Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol (1993) 1.03
Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159. Br J Radiol (1976) 1.03
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res (1995) 1.03
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol (2001) 1.03
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res (1994) 1.02
Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer (1995) 1.02
Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol (2008) 1.02
Separation of cells from a murine fibrosarcoma on the basis of size. II. Differential effects of cell size and age on lung retention and colony formation in normal and preconditioned mice. J Natl Cancer Inst (1978) 1.02
Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry (1985) 1.01
Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys (1994) 1.01
Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys (1990) 1.01
Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res (1987) 1.01
Paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg (1988) 1.00
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res (1994) 1.00
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer Suppl (1984) 1.00
The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys (1990) 0.99
Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug. Anticancer Drugs (1996) 0.99
Spontaneous metastasis: random or selective? Clin Exp Metastasis (1986) 0.99